Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine

Recruiting

• Conditions: Cardiovascular Diseases
• Interventions: Drug: Chinese patent medicine

• Registration Number: NCT05309343
• Lead Sponsor: Tianjin University of Traditional Chinese Medicine

Brief Summary

This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-01
• Status Verified: 2022-03
• Study First Submitted: 2022-03-25
• Study First Submitted QC: 2022-03-25
• Last Update Submitted: 2022-03-25
• Study First Posted: 2022-04-04
• Last Update Posted: 2022-04-04
• Primary Completion: 2024-04-01
• Study Completion: 2031-11-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

All patients admitted to the Department of Cardiovascular Medicine at The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital, Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital were considered for inclusion in this study, and all Western medical diagnoses were identified and classified according to the International Classification of Diseases, 11th Revision (ICD-11).

Exclusion Criteria

No exclusion criteria.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Exposed group	Chinese patent medicine	Western medicine treatment with Chinese medicine treatmen

Primary Outcome Measures

Name	Time	Method
All due to readmission	one year	Readmission for cardiovascular events and readmission for other reasons.
Cardiovascular Events Cardiovascular Events Cardiovascular Events	one year	Non-fatal myocardial infarction, non-fatal ischemic stroke, unplanned hemodynamic reconstruction.
All due to death	one year	Cardiac death and death from other causes.

Trial Locations

Locations (1)

Tianjin University of Traditional Chinese Medicine; 🇨🇳 Tianjin, China